Narcotic bowel syndrome · testing

Narcotic Bowel Syndrome: What Testing Can and Cannot Show

The gut side of narcotic bowel syndrome is measured with transit scintigraphy, intestinal pressure studies and breath tests, done in gastroenterology settings and each with blind spots. The rest of long-term opioid therapy can be measured too: attention on cognitive assessment, and metabolic health on laboratory panels and bioimpedance body composition.

A bowel that slows on long-term pain medication usually gets charted as a nuisance. The first brain, the second brain and the metabolism around them can all be measured, and most of it never is.

Narcotic bowel syndrome is abdominal pain that gets worse even while the pain medication meant to control it holds steady or climbs. It sits at the far end of a much more common problem: a bowel that slows on long-term opioid therapy and gets written off as a nuisance. The Pain Pill That Paralyzes Your Gut, the video chapter of The Angry Gut by Dr. Gurpreet Singh Padda, MD, MBA, MHP, and Ami Michelle Grimes, makes the clinical argument. The angle here is what can be measured: which gut tests exist, which ones are done somewhere else, and what else in your body is worth putting on a number.

Why does opioid constipation so often go unreported?

Most people do not bring it up. In a European study of 1,200 people with cancer who were taking opioids, 59.5% met formal criteria for opioid-induced constipation, yet only 61.5% of that group described themselves as constipated. Roughly four in ten had a measurably stalled bowel and said nothing.

Those who do mention it often stay stuck. Among 322 survey respondents on an opioid plus a laxative, 81% remained constipated, and about a third had skipped, reduced or stopped their pain medication just to have a bowel movement. That is a dose change made alone, without the person who wrote the prescription knowing.

The reasons are partly economic. A short appointment rewards whatever takes seconds, and a stool softener takes seconds. The question that uncovers the real burden takes minutes. The cost is also social: a person who skips food before leaving the house soon stops leaving it, and loneliness is one of the drivers of chronic pain, not a side note to it.

How do opioids affect the gut?

The gut is the first brain, with its own nerve networks in the bowel wall, and the skull holds the second. An opioid aimed at pain lands wherever its receptor sits, and in the human gut that receptor lines both nerve networks, the immune cells under the lining, and both halves of the reflex that pushes contents forward.

I was taught that opioids simply shut the bowel off, and I repeated it. Recordings in people showed something stranger. Intravenous morphine drove bursts of contraction in the upper small intestine in nine of ten volunteers, firing out of their normal cycle. Contraction without direction does not move anything along. Three days of codeine in healthy volunteers slowed stomach emptying, with a half-time of 144.0 minutes against 95.5, and colonic filling at six hours fell to 11.0% from 51%.

The body builds tolerance to the pain relief. It does not build tolerance to the bowel effect, which persists. As doses rise to chase a pain that adapts, the gut absorbs each increase in full. The practice position is that a stagnant bowel feeds metaflammation, the low-grade inflammation of a disordered metabolism, and that metaflammation turns up the central pain signal. Each end of that chain has been shown in people; the connection between them has been seen in tissue and animals, and no human trial has tested it.

Motility testing is a different test, done elsewhere

Measura [Cardiometabolic and Autonomic Health Analysis] does not measure gut motility. Transit scintigraphy, which follows a labeled meal through the gut, pressure studies of the intestine and breath tests are gastroenterology tests performed in other settings. Each has blind spots. Transit timing says little about the contractions themselves, and the morphine recordings captured when contractions started, not whether they traveled.

Breath testing is shakier still. In a clinic series of 525 breath tests, post-surgical patients taking more motility-slowing drugs, opioids among them, tested positive less often. The researchers’ reading was that the result may reflect how fast contents move rather than bacteria. A result from that instrument deserves careful interpretation before anyone acts on it.

The second brain: attention and cognitive assessment

What long-term therapy does upstairs is measurable. In a small study of chronic low back pain, people on daily opioids for three months or longer were compared with people who had the same pain and took no opioids. The opioid group performed significantly worse on attention and reported lower confidence in managing their pain. Cognitive assessment puts attention, memory and processing on a documented baseline, so a change can be seen instead of guessed at. More on why a baseline matters is in memory and cognitive screening.

Pain processing shifts as well. About 6% of long-term narcotic users develop narcotic bowel syndrome, which is thought to originate in the central nervous system rather than the bowel. Across 27 randomized surgical trials, higher opioid doses during surgery were followed by slightly worse pain afterward. These are findings to discuss with your prescriber, not instructions to act on.

Blood work, body composition and the terrain trials leave out

In that same back pain study, blood cytokines, the chemical messengers of inflammation, showed only minor differences between opioid users and non-users. Blood sits downstream of the gut lining, so a quiet blood panel does not prove a quiet bowel. It does not make blood work pointless either. Trials routinely exclude people with diabetes, depression or fatty liver, which is the terrain many long-term patients actually live in. Laboratory panels and bioimpedance body composition measure that metabolic side directly, and insulin resistance and metabolic health explains why it shapes pain.

The gut microbiome changes too, though Measura does not test stool. In five opioid users in an addiction-treatment sample, microbial diversity was lower, and two groups of bacteria tied to butyrate and bile handling were depleted. Five people is a signal, not a verdict.

What autonomic testing can and cannot add

The morphine effect on the small intestine was blocked by atropine, which means it runs on the same acetylcholine wiring the vagus nerve uses. That makes the bowel problem autonomic in a strict sense. Autonomic nervous system testing, however, reads how the involuntary nervous system regulates heart rate, blood pressure and sweating. It does not record the bowel, and none of the opioid studies here tie an autonomic result to constipation. It belongs in the picture when you have symptoms such as lightheadedness on standing, described in autonomic symptoms, not as a stand-in for a gut test.

What to bring to your next appointment

• How many bowel movements you have in a week, and how many days you strain.
• When your dose last went up, and whether your bowel changed in the weeks after.
• Any time you took a dose late, lowered it or skipped it to have a bowel movement.
• Whether constipation sits on your problem list or only under side effects.
• Any change in attention, memory or confidence you have noticed.

More prompts are in chronic pain and metabolic health. Every study cited above, with what it does not show, is gathered in The Angry Gut deep dive on the narcotic bowel. Clinicians can read the screening version for practices, and long-term PPI use covers the acid pill that stalls digestion higher up.

Frequently asked questions

What is narcotic bowel syndrome?

It is abdominal pain that intensifies even though the opioid dose used to treat it stays the same or rises. Roughly 6% of long-term narcotic users develop it, and it is thought to arise in the central nervous system, though it often travels with constipation. Any change in treatment is a decision for the physician managing your pain. See why metabolic health belongs in a pain practice.

Will my body get used to the constipation over time?

Usually not. Tolerance tends to develop to the pain-relieving effect of opioids, which is why doses creep upward, but guideline reviews describe the bowel effect as persistent and in need of long-term management. Waiting for it to settle on its own tends to leave it untreated for years. Raise it directly with your prescriber. Learn what a test result can and cannot tell you.

Can Measura test my gut motility?

No. Transit studies, intestinal pressure studies and breath tests are gastroenterology tests done elsewhere. Measura measures the wider picture, including cognitive function, laboratory panels, body composition and autonomic regulation, and sends results to your physician. Those results do not show how your bowel is moving, and a normal one does not rule out a bowel problem. See what Measura actually measures.

Can long-term pain medication affect attention or memory?

It can affect attention. In a small study of people with chronic low back pain, those on daily opioids for three months or longer scored significantly worse on attention than people with the same pain who took none. A cognitive assessment gives you and your physician a measured baseline instead of an impression. Learn about cognitive assessment.

Is it okay to skip a dose to have a bowel movement?

Tell your prescriber rather than managing it alone. About a third of people in one survey had skipped, lowered or stopped their opioid to have a bowel movement, which amounts to an unsupervised change in pain treatment. Your physician needs that information to plan both the bowel and the pain together. Bring these questions to your doctor.

What causes narcotic bowel syndrome?

It is thought to start in the central nervous system rather than the bowel. The body builds tolerance to the pain relief but not to the bowel effect, so as doses rise to chase a pain that adapts, the gut absorbs each increase in full. The practice position is that a stagnant bowel feeds metaflammation, and metaflammation turns up the central pain signal.

How is opioid-induced bowel dysfunction treated?

A laxative alone often falls short: in one survey of people taking an opioid plus a laxative, 81% were still constipated. Guideline reviews describe the bowel effect as persistent and in need of long-term management, so it belongs on your problem list, not only under side effects. Bring your weekly bowel count and any dose you skipped, and plan the bowel and the pain together with your prescriber.

References

• Davies, A., Fagan, N., Gonzalez-Barboteo, J., Chelazzi, C., Economos, G., Elsner, F., Leach, C., Monsen, R. E., Oldenmenger, W. H., Remi, C., van den Beuken-van Everdingen, M., & Wüstefeld, M. (2024). Inadequate management of opioid-induced constipation in European cancer pain patients: Results of a real-world, multicentre, observational study (“E-StOIC”). Supportive Care in Cancer, 32(10), 701. https://doi.org/10.1007/s00520-024-08898-1
• Bell, T. J., Panchal, S. J., Miaskowski, C., Bolge, S. C., Milanova, T., & Williamson, R. (2009). The prevalence, severity, and impact of opioid-induced bowel dysfunction: Results of a US and European patient survey (PROBE 1). Pain Medicine, 10(1), 35-42. https://doi.org/10.1111/j.1526-4637.2008.00495.x
• Sternini, C., Patierno, S., Selmer, I.-S., & Kirchgessner, A. (2004). The opioid system in the gastrointestinal tract. Neurogastroenterology and Motility, 16(Suppl 2), 3-16. https://doi.org/10.1111/j.1743-3150.2004.00553.x
• Lewis, T. D. (1999). Morphine and gastroduodenal motility. Digestive Diseases and Sciences, 44(11), 2178-2186. https://doi.org/10.1023/a:1026684132254
• Halawi, H., Vijayvargiya, P., Busciglio, I., Oduyebo, I., Khemani, D., Ryks, M., Rhoten, D., Burton, D., Szarka, L. A., Acosta, A., & Camilleri, M. (2018). Effects of naloxegol on whole gut transit in opioid-naïve healthy subjects receiving codeine: A randomized, controlled trial. Neurogastroenterology and Motility, 30(5), e13298. https://doi.org/10.1111/nmo.13298
• Manabe, N., Ihara, E., Yomiya, K., Iseki, M., Torii, A., Miwa, H., & Camilleri, M. (2026). Current strategies and future perspectives in the management of opioid-induced constipation: A review of international and Japanese guidelines. Neurogastroenterology and Motility, 38(5), e70343. https://doi.org/10.1111/nmo.70343
• Drossman, D., & Szigethy, E. (2014). The narcotic bowel syndrome: A recent update. American Journal of Gastroenterology Supplements, 2(1), 22-30. https://doi.org/10.1038/ajgsup.2014.6
• Richards, G. C., Lluka, L. J., Smith, M. T., Haslam, C., Moore, B., O’Callaghan, J., & Strong, J. (2018). Effects of long-term opioid analgesics on cognitive performance and plasma cytokine concentrations in patients with chronic low back pain: A cross-sectional pilot study. Pain Reports, 3(4), e669. https://doi.org/10.1097/PR9.0000000000000669
• Essa, H., Hamdy, S., Green, D., Lal, S., McLaughlin, J., Hoffmann, S., Leitao, E., & Paine, P. (2021). Hydrogen and methane breath test results are negatively associated with IBS and may reflect transit time in post-surgical patients. Neurogastroenterology and Motility, 33(6), e14033. https://doi.org/10.1111/nmo.14033
• Gicquelais, R. E., Bohnert, A. S. B., Thomas, L., & Foxman, B. (2020). Opioid agonist and antagonist use and the gut microbiota: Associations among people in addiction treatment. Scientific Reports, 10(1), 19471. https://doi.org/10.1038/s41598-020-76570-9

Related reading

• Long-Term PPI Use: What Your Blood Work and Body Can Show
• Glyphosate in Food: What Can Actually Be Measured in You
• Cognitive Assessment

Medically reviewed by Dr. Gurpreet Singh Padda, MD, MBA, MHP, medical director of Measura. Last reviewed September 12, 2026.